博九娱乐网

Cellectar Biosciences is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company is developing proprietary drugs independently and through research and development collaborations. The company鈥檚 core objective is to leverage its proprietary Phospholipid Drug Conjugate鈩� (PDC) delivery platform to develop PDCs that specifically target cancer…More cells, delivering improved efficacy and better safety as a result of fewer off-target effects. The company鈥檚 PDC platform possesses the potential for the discovery and development of the next-generation of cancer-targeting treatments, and it plans to develop PDCs independently and through research and development collaborations.